Comments
Shire withdraws FDA application for Fabry drug
15.03.2012. | (Reuters) - Shire Plc has pulled its application to the U.S. Food and Drug Administration for approval of its drug to treat Fabry disease, a rare genetic disorder, because the agency likely will require more clinical studies, the company said on Wednesday....
